20–22 November 2017
The Cutting Edge Science Symposium on Genome Engineering for Cancer Treatment (The Frank and Bobbie Fenner Conference), will be held in Canberra 20-22 November 2017.
The symposium will explore the ...
2–3pm 22 November 2017
Thilaga Velusamy, The Tscharke Group, JCSMR
Can ICP47 hide HSV from CD8+ T cells?
(Final PhD Presentation)
Please note the change of time for this week.
12–1pm 24 November 2017
Professor Lars Nitschke, PhD, Division of Genetics, Department of Biology, University of Erlangen, Germany
The Nitschke group works on Siglec proteins, which are inhibiting receptors on immune cells that can bind sialic...
5.30–6.15pm 27 November 2017
Evidence based medical and science policy is increasingly under pressure to bow to commercial pressures and political ideology. But surely not in Australia...?
Should academics respond by staying removed, &...
12–1pm 8 December 2017
Dr Daniel Hu
Highly self-reactive T cells within the thymus undergo apoptosis when they encounter their cognate antigens, and so are “negatively selected” from the conventional T cell fate. This process occurs at...
12–1pm 15 December 2017
Dr James Wang, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA
Activated B cell like diffuse large B cell lymphoma (ABC-DLBCL) is an aggressive and incurable form of B cell malignancy. A hallmark...